Aurobindo Pharma Ltd. (AUROPHARMA) Share Price Hits Fresh 52-Week High
- August 7, 2026
- Posted by: Harsh Piplani
- Category: News
Aurobindo Pharma Ltd. Share Price rose to Rs 1,634.7, up 2.84% today, after hitting a fresh 52-week high of Rs 1,638.8. Market capitalisation stands at Rs 92,831.47 crore.
Aurobindo Pharma Ltd. Share Price was at Rs 1,634.7 on 07 August 2026 at 12:19 PM IST, up Rs 45.2 or 2.84% from the previous close of Rs 1,589.5, after touching a fresh 52-week high of Rs 1,638.8. With a market capitalisation of Rs 92,831.47 crore, the move places the stock among notable healthcare names in Stock Market Today and keeps Aurobindo Pharma Ltd. Stock News firmly on investor radar.
The verified data confirms the price event clearly: the stock opened at Rs 1,588, slipped to a day low of Rs 1,579.3, and then climbed to a new one-year high of Rs 1,638.8. Turnover stood at Rs 10.84 crore on current volume of 66,336 shares. That combination makes the move relevant because it reflects a decisive intraday expansion from the open and a successful push above prior yearly trading levels.
What the supplied data establishes is the fresh 52-week high itself, the day’s gain, and the company’s valuation and sector context. It does not establish a company-specific catalyst, so the market focus shifts to what the numbers do show: price strength, a large market cap within Healthcare, and fundamental ratios that sit quite differently from broad sector medians. Univest is tracking the move as a data-led Aurobindo Pharma Ltd. Share Price Update rather than a speculative narrative.
Aurobindo Pharma Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,634.7 |
| Previous Close | Rs 1,589.5 |
| Today's Change | +Rs 45.2 (+2.84%) |
| Day Open | Rs 1,588 |
| Fresh 52-Week High | Rs 1,638.8 |
| Day Low | Rs 1,579.3 |
| Current Volume | 66,336 |
| Turnover | Rs 10.84 crore |
| Market Capitalisation | Rs 92,831.47 crore |
Aurobindo Pharma Ltd. (AUROPHARMA) traded at Rs 1,634.7. versus the previous close of Rs 1,589.5, a rise of 2.84%. The stock opened at Rs 1,588, reached Rs 1,638.8, touched Rs 1,579.3. Reported volume was 66,336.
Aurobindo Pharma Ltd. Share Price Today shows a firm upward session, with the stock moving from Rs 1,588 at the open to a fresh 52-week peak of Rs 1,638.8 before trading at Rs 1,634.7. The gain of 2.84% over the previous close of Rs 1,589.5 highlights clear intraday strength, while turnover of Rs 10.84 crore and volume of 66,336 indicate active participation.
From a pure price-action perspective, the stock’s path through the session matters. It opened marginally below the previous close, dipped to Rs 1,579.3, and then reversed sharply enough to print the day high at the exact 52-week high level of Rs 1,638.8. That leaves Aurobindo Pharma Ltd. Share Price close to the best level of the day, a detail that often keeps traders and longer-term market participants watching the tape closely.
The absolute day change of Rs 45.2 is meaningful when read alongside the day’s range. Between the day low of Rs 1,579.3 and the day high of Rs 1,638.8, the stock covered a swing of Rs 59.5. This kind of range expansion is one reason Aurobindo Pharma Ltd. Share News can appear among Market Movers and 52 Week High Stocks during the session.
The current reading also shows that the stock not only touched a fresh yearly high but continued to hold near that zone. In market structure terms, that keeps attention on whether the stock can sustain trade above the breakout area rather than simply spike into it. Univest notes that the verified data supports a strong daily move, and that naturally shifts the discussion from raw Price Action to whether the underlying valuation and profitability metrics support continued investor attention.
Aurobindo Pharma Ltd. (AUROPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 92,831.47 crore |
| P/E Ratio | 31.3x |
| P/B Ratio | 0.46x |
| ROE | -2.89% |
| ROCE | -0.26% |
Aurobindo Pharma Ltd. was valued at a P/E ratio of 31.3x, a P/B ratio of 0.46x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 31.3x |
| Benchmark Median P/E | 21.48x |
| Benchmark Average P/E | 72.73x |
| Benchmark P/E Range | 0x to 3,493.04x |
| Company P/B Ratio | 0.46x |
| Benchmark Median P/B | 1.94x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.75% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 92,831.47 crore |
| Benchmark Median Market Cap | Rs 140.58 crore |
Aurobindo Pharma Ltd. (AUROPHARMA) is classified under sector: Healthcare.
Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 31.3x, which is above the benchmark median of 21.48x, a difference of +45.72%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aurobindo Pharma Ltd. (AUROPHARMA) has a ROE of -2.89%, which is below the benchmark median of 10.75%, a difference of -126.88%. Aurobindo Pharma Ltd. (AUROPHARMA) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 3,060.41 | 31.3 | 0.46 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,652.52 | 40.87 | 8.32 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,623.92 | 67.31 | 10.65 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,537.31 | 33.29 | 6.86 | -2.6 | 16.92 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,290.47 | 167.74 | 3.1 | 13.9 | 12.97 |
Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 31.3x compared with the displayed peer median of 40.87x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Aurobindo Pharma Ltd. (AUROPHARMA) has a market capitalisation of Rs 92,831.47 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. Share Price is drawing attention because the stock has delivered a clear price breakout to a fresh 52-week high while also presenting unusual contrasts in valuation, profitability and relative scale versus the Healthcare benchmark and supplied peers.
- The stock rose 2.84% or Rs 45.2 to Rs 1,634.7 and touched a fresh 52-week high of Rs 1,638.8.
- Intraday movement from Rs 1,579.3 to Rs 1,638.8 shows a wide session range, with turnover of Rs 10.84 crore and volume of 66,336 shares.
- Market capitalisation of Rs 92,831.47 crore makes it far larger than the supplied sector benchmark range and the listed peer set.
- P/E of 31.3 is above the sector median of 21.48 but below the sector average of 72.73, while P/B of 0.46 is below both sector median and average.
- ROE of -2.89 and ROCE of -0.26 are below sector medians and below most supplied peers, adding an important counterbalance to the Price Action.
- For investors tracking Stocks in News and Breakout Stocks, the move stands out because the supplied data confirms the event clearly even without a verified company-specific catalyst.
About Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. is identified in the supplied data as a Healthcare sector company trading under the symbol AUROPHARMA. In this article’s verified framework, the stock is being assessed against Healthcare companies and peers that include Pharmaceuticals & Drugs names such as Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Beta Drugs Ltd. and Sai Parenteral’s Ltd., along with Dr Agarwals Eye Hospital Ltd. from Hospital & Healthcare Services.
That context places Aurobindo Pharma Ltd. within the broader Healthcare universe for sector, valuation and peer analysis. The stock’s current market capitalisation of Rs 92,831.47 crore also makes it much larger than the supplied companies used for benchmark comparison. For readers following Aurobindo Pharma Ltd. Latest News, Aurobindo Pharma Ltd. NSE screens or broader BSE and NSE News categories, the key takeaway is that the company is being watched today because it has reached a fresh one-year high within the Healthcare space. Univest will continue to track Aurobindo Pharma Ltd. Company News through verified price, valuation and market-structure data.
Track Aurobindo Pharma Ltd. Share Price on Univest
Use Aurobindo Pharma Ltd. (AUROPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Aurobindo Pharma Ltd. Share Price can be tracked on Univest through live price movement, 52-week levels, market cap, valuation ratios, sector comparison and broader stock analysis tools. For investors following Aurobindo Pharma Ltd. Share Price Live, Aurobindo Pharma Ltd. Stock News and Aurobindo Pharma Ltd. Shareholding Pattern updates, Univest provides a structured way to monitor verified market data.
That matters especially on days like this, when a fresh 52-week high can trigger interest across Share Market Today, NSE News and Market Trends screens. On Univest, users can keep track of Aurobindo Pharma Ltd. Share Price Today, compare the stock with Healthcare peers, and review how market-cap scale, P/E, P/B, ROE and ROCE fit into the broader investment picture without turning the data into a recommendation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the latest Aurobindo Pharma Ltd. Share Price Today?
Ans. Aurobindo Pharma Ltd. Share Price Today was Rs 1,634.7 at 12:19 PM IST on 07 August 2026. The stock was up Rs 45.2, or 2.84%, from the previous close of Rs 1,589.5.
Did Aurobindo Pharma Ltd. hit a fresh 52-week high today?
Ans. Yes, Aurobindo Pharma Ltd. touched a fresh 52-week high of Rs 1,638.8 during the session. The stock later traded at Rs 1,634.7, showing that it remained close to the day’s strongest level.
Why is Aurobindo Pharma Ltd. rising today?
Ans. The supplied data confirms that the stock rose 2.84% and hit a fresh one-year high of Rs 1,638.8. It establishes the price event clearly, though it does not identify a company-specific catalyst for the move.
What were the day’s opening, low and high levels for Aurobindo Pharma Ltd.?
Ans. Aurobindo Pharma Ltd. opened at Rs 1,588, fell to a day low of Rs 1,579.3, and then climbed to Rs 1,638.8. That intraday swing highlights strong price expansion during the current trading session.
What is the market capitalisation of Aurobindo Pharma Ltd.?
Ans. Aurobindo Pharma Ltd. has a market capitalisation of Rs 92,831.47 crore. That is far above the supplied same-sector benchmark average of Rs 471.12 crore and the benchmark maximum of Rs 3,060.41 crore.
How is Aurobindo Pharma Ltd. valued on P/E and P/B?
Ans. The stock is trading at a P/E ratio of 31.3 and a P/B ratio of 0.46. Its P/E is above the sector median of 21.48, while its P/B is below the sector median of 1.94.
How do Aurobindo Pharma Ltd. ROE and ROCE compare with the sector?
Ans. Aurobindo Pharma Ltd. has ROE of -2.89 and ROCE of -0.26 on the supplied data. Both are below the Healthcare sector median values of 10.75 for ROE and 13.29 for ROCE.
How does Aurobindo Pharma Ltd. compare with the supplied peers?
Ans. Aurobindo Pharma Ltd. has a much larger market cap than the supplied peers, while its P/E of 31.3 sits below several names. Its P/B of 0.46 is also lower, but ROE and ROCE trail most peers.
What were the turnover and trading volume in Aurobindo Pharma Ltd. today?
Ans. The stock recorded turnover of Rs 10.84 crore with current volume of 66,336 shares. These figures show active trading participation alongside the move to a fresh 52-week high during the session.
What should investors monitor next in Aurobindo Pharma Ltd. Share Price News?
Ans. Investors may watch whether Aurobindo Pharma Ltd. holds near Rs 1,638.8 after this fresh yearly high. Valuation at 31.3 times earnings, P/B of 0.46 and negative ROE and ROCE remain important context points.
